These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10627478)

  • 21. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
    Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
    Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease.
    Azuma H; Oomi H; Sasaki K; Kawabata I; Sakaino T; Koyano S; Suzutani T; Nunoi H; Okuno A
    Blood; 1995 Jun; 85(11):3274-7. PubMed ID: 7756659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.
    Vergnaud S; Paclet MH; El Benna J; Pocidalo MA; Morel F
    Eur J Biochem; 2000 Feb; 267(4):1059-67. PubMed ID: 10672014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.
    Matute JD; Arias AA; Wright NA; Wrobel I; Waterhouse CC; Li XJ; Marchal CC; Stull ND; Lewis DB; Steele M; Kellner JD; Yu W; Meroueh SO; Nauseef WM; Dinauer MC
    Blood; 2009 Oct; 114(15):3309-15. PubMed ID: 19692703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox.
    Raad H; Paclet MH; Boussetta T; Kroviarski Y; Morel F; Quinn MT; Gougerot-Pocidalo MA; Dang PM; El-Benna J
    FASEB J; 2009 Apr; 23(4):1011-22. PubMed ID: 19028840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody 7D5 recognizes the R147 epitope on the gp91
    Kawai C; Yamauchi A; Kuribayashi F
    Microbiol Immunol; 2018 Apr; 62(4):269-280. PubMed ID: 29573449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
    Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
    Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
    Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
    Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
    Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
    Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets.
    Leto TL; Adams AG; de Mendez I
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10650-4. PubMed ID: 7938008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The phagocyte 47-kilodalton cytosolic oxidase protein is an early reactant in activation of the respiratory burst.
    Kleinberg ME; Malech HL; Rotrosen D
    J Biol Chem; 1990 Sep; 265(26):15577-83. PubMed ID: 2168417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the membrane topology of the phagocyte NADPH oxidase: characterization of an anti-gp91-phox conformational monoclonal antibody.
    Campion Y; Paclet MH; Jesaitis AJ; Marques B; Grichine A; Berthier S; Lenormand JL; Lardy B; Stasia MJ; Morel F
    Biochimie; 2007 Sep; 89(9):1145-58. PubMed ID: 17397983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
    Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox.
    Zhou H; Zhang F; Chen SH; Zhang D; Wilson B; Hong JS; Gao HM
    Free Radic Biol Med; 2012 Jan; 52(2):303-13. PubMed ID: 22094225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurine chloramine inhibits PMA-stimulated superoxide production in human neutrophils perhaps by inhibiting phosphorylation and translocation of p47(phox).
    Choi HS; Cha YN; Kim C
    Int Immunopharmacol; 2006 Sep; 6(9):1431-40. PubMed ID: 16846837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic granulomatous disease and glutathione peroxidase deficiency, revisited.
    Newburger PE; Malawista SE; Dinauer MC; Gelbart T; Woodman RC; Chada S; Shen Q; van Blaricom G; Quie PG; Curnutte JT
    Blood; 1994 Dec; 84(11):3861-9. PubMed ID: 7949143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C-terminal flavin domain of gp91phox bound to plasma membranes of granulocyte-like X-CGD PLB-985 cells is sufficient to anchor cytosolic oxidase components and support NADPH oxidase-associated diaphorase activity independent of cytosolic phospholipase A2 regulation.
    Pessach I; Shmelzer Z; Leto TL; Dinauer MC; Levy R
    J Leukoc Biol; 2006 Sep; 80(3):630-9. PubMed ID: 16844764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
    Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
    Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.
    Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C
    Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.